Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04933461 · ClinicalTrials.gov registry record · NA
Simulated Clinical Use Testing to Evaluate Sharps Injury Prevention Features of HTL-STREFA's Safety Lancets (Test C)
A NA study, sponsored by HTL-Strefa S.A..
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04933461 is a NA study that has completed, run by HTL-Strefa S.A.. The registered enrollment target is 20 participants.
The verdict
NCT04933461, a NA study, has completed, sponsored by HTL-Strefa S.A..
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A simulated clinical use testing to evaluate the Medlance Plus and myLance sharps injury prevention feature in accordance with the FDA's guidance on medical devices with sharps injury prevention features.
Interventions
- DEVICE Safety lancet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-09-24 |
| Est. Completion | 2019-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04933461
The ClinicalTrials.gov registry entry for NCT04933461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HTL-Strefa S.A., which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Safety lancet is the first listed.
NCT04933461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04933461 about?
NCT04933461 is a clinical study titled "Simulated Clinical Use Testing to Evaluate Sharps Injury Prevention Features of HTL-STREFA's Safety Lancets (Test C)". A simulated clinical use testing to evaluate the Medlance Plus and myLance sharps injury prevention feature in accordance with the FDA's guidance on medical devices with sharps injury prevention features.
What is the current status of trial NCT04933461?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-09-24. Estimated completion is 2019-09-27.
What interventions are being tested in trial NCT04933461?
The interventions under investigation include: Safety lancet (DEVICE).
Who is sponsoring clinical trial NCT04933461?
This trial is sponsored by HTL-Strefa S.A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.